Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301210 · ClinicalTrials.gov registry record · Phase 1
Assessment of Tramadol as a Treatment for Opioid Addiction
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00301210: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT00301210 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301210, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Opioids are one of the most commonly abused drugs among individuals who seek treatment for drug abuse. Thus, it is necessary to develop new treatments for opioid addiction. The purpose of this trial is determine whether tramadol is effective in treating opioid dependent individuals.
Interventions
- DRUG Tramadol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00301210
The ClinicalTrials.gov registry entry for NCT00301210 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tramadol is the first listed.
NCT00301210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00301210 about?
NCT00301210 is a clinical study titled "Assessment of Tramadol as a Treatment for Opioid Addiction". Opioids are one of the most commonly abused drugs among individuals who seek treatment for drug abuse. Thus, it is necessary to develop new treatments for opioid addiction. The purpose of this trial is determine whether tramadol is effective in treating opioid dependent individuals.
What is the current status of trial NCT00301210?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2006-01. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00301210?
The interventions under investigation include: Tramadol (DRUG).
Who is sponsoring clinical trial NCT00301210?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.